*Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements
Kuehn Law Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law Firm Newsfile Corp
Market data is delayed by at least 15 minutes.
    Latest Story Top Stories on ZNTL
    No News Available
    Zentalis Pharmaceuticals to Present at TD Cowen 5th Annual Oncology I...
    7:00a ET May 14 '24 GlobeNewswire
    Zentalis Pharmaceuticals Reports First Quarter 2024 Financial Results...
    7:00a ET May 7 '24 GlobeNewswire
    Kuehn Law Encourages Investors of Zentalis Pharmaceuticals, Inc. to C...
    10:49a ET May 3 '24 Newsfile Corp
    Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Lis...
    5:30p ET May 1 '24 GlobeNewswire
    Zentalis Pharmaceuticals to Highlight Preclinical Data Demonstrating ...
    4:05p ET April 2 '24 GlobeNewswire
    Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Lis...
    5:30p ET April 1 '24 GlobeNewswire
    Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Lis...
    6:00p ET March 1 '24 GlobeNewswire
    Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferen...
    7:00a ET February 28 '24 GlobeNewswire
    Zentalis Pharmaceuticals Reports Full Year 2023 Financial Results and...
    7:00a ET February 27 '24 GlobeNewswire

    Market data provided by News provided by